Hoe kunnen - op basis van fundamenteel neurowetenschappelijk onderzoek ontwikkelde - biomarkers worden ingezet bij het vaststellen van de aard en prognose van stress-gerelateerde psychiatrische aandoeningen (depressie, angst, verslaving)?

Stress-related disorders like psychosis, depression, anxiety and addiction have a worldwide impact on mental and physical health. New strategies in personalized health care by determining individual sensitivity and optimally combining pharmacological, psychotherapeutic and neuromodulatory approaches are needed. As closely collaborating interdisciplinary researchers we aim to decrease the burden of these highly prevalent disorders by a better understanding of their development, characteristics and consequences. We aim to develop both new biomarkers and individualized treatments.